Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis”

2,445 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,445 results

Large-scale testing (Phase 3)Study completedNCT00723528
What this trial is testing

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 158
Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Large-scale testing (Phase 3)Study completedNCT03022045
What this trial is testing

Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Psoriasis
AbbVie 18
Not applicableStudy completedNCT04655612
What this trial is testing

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

Who this might be right for
COVID-19SARS-CoV InfectionRheumatoid Arthritis+3 more
University Hospital, Montpellier 5,000
Testing effectiveness (Phase 2)Study completedNCT00428974
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 76
Not applicableUnknownNCT01504113
What this trial is testing

The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis

Who this might be right for
Psoriasis
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Study completedNCT01952015
What this trial is testing

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 12
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT03671148
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

Who this might be right for
Psoriatic Arthritis (PsA)
AbbVie 444
Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00929578
What this trial is testing

Fluphenazine Hydrochloride for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT06176768
What this trial is testing

LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 33
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Large-scale testing (Phase 3)WithdrawnNCT02795416
What this trial is testing

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Not applicableActive Not RecruitingNCT05913817
What this trial is testing

The Evaluation of Injection Site Pain and Adherence in Patients Switching from a Low to High Concentration Adalimumab (AVT-02) Across Multiple Indications.

Who this might be right for
Crohn DiseaseUlcerative ColitisRheumatoid Arthritis+4 more
Jamp Pharma Corporation 600
Large-scale testing (Phase 3)Study completedNCT01947491
What this trial is testing

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Who this might be right for
Psoriasis
Primus Pharmaceuticals 394
Large-scale testing (Phase 3)Study completedNCT01195831
What this trial is testing

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
LEO Pharma 244
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Not applicableStudy completedNCT02382081
What this trial is testing

Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis

Who this might be right for
Psoriasis
University Hospital, Gentofte, Copenhagen 150
Post-approval studies (Phase 4)Study completedNCT03718299
What this trial is testing

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries Limited 55
Load More Results